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2 
ABSTRACT  1 
This observational study aimed to i) compare accuracy of information recalled by 2 
patients and relatives following genetic counselling about a newly identified BRCA1/2 3 
mutation; ii) identify differences in accuracy about genetics and hereditary cancer and 4 
iii) investigate whether accuracy amongst relatives improved when information was 5 
provided directly by genetics health professionals. Semi-structured interviews 6 
following results consultations with 10 breast/ ovarian cancer patients and 22 relatives 7 
were audio-recorded and transcribed. Information provided by the genetics health 8 
professional was tracked through the families and coded for accuracy. Accuracy was 9 
analysed using the Wilcoxon Signed Ranks test. Sources of information were tested 10 
using a Spearman’s rank order correlation coefficient. 53% of the information 11 
recalled by patients was accurate. Accuracy of recall amongst relatives was 12 
significantly lower than amongst patients (p=0.017). Both groups recalled a lower 13 
proportion of information about hereditary cancer than genetics (p=0.005). Relatives 14 
who learnt the information from the patient alone recalled significantly less accurate 15 
information than those informed directly by genetics health professionals (p=0.001). 16 
Following genetic counselling about a BRCA1/2 mutation, accuracy of recall was low 17 
amongst patients and relatives, particularly about hereditary cancer. Multiple sources 18 
of information, including direct contact with genetics health professionals, may 19 
improve accuracy of information amongst relatives. 20 
 21 
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INTRODUCTION 1 
One of the goals of genetic counselling in the context of familial cancer risk is to 2 
provide relevant information in order to enable informed decision-making about 3 
genetic testing and risk management 
1
. Until recently, genetic testing has generally 4 
been offered to women with breast or ovarian cancer after completing cancer 5 
treatment. However, BRCA1/2 testing is increasingly offered to women with newly 6 
diagnosed breast cancer as part of their oncology management 
2
. Thus the information 7 
that the patient understands and recalls about a cancer predisposing gene mutation 8 
may impact on treatment decisions as well on as the management of future cancer 9 
risks for herself and her relatives 
3,4
.  10 
 11 
Responsibility for sharing information within families once a cancer predisposing 12 
gene mutation has been identified generally falls to the individual with cancer who 13 
receives the initial mutation result 
5
.  Families prefer information to be passed on by 14 
the patient 
6
 yet, although most families do appear to communicate genetic 15 
information 
5
, patients do not always share all information with all at risk relatives 
7,8
.  16 
There are many barriers to family communication about hereditary cancer 
9
 including 17 
lack of close relationship 
6
, reluctance to upset relatives 
10
, youth or emotional 18 
readiness of relatives 
11
, family culture 
8
, perception of the risks and benefits of the 19 
information 
12
 and personal beliefs about the causes of genetic illness 
13
.  20 
 21 
Information about a cancer predisposing gene mutation does not necessarily lead to 22 
changes in risk perception 
1
, although the way in which information is communicated 23 
within families may influence uptake of genetic counselling and screening 
14
 . 24 
However at risk individuals who are unaware of the implications of a mutation or the 25 
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available screening protocols may be unable to make informed decisions about 1 
whether or not to access genetic testing or screening.  For example, in the UK 2 
untested women at 50% risk of a known BRCA1/2 gene mutation are eligible for 3 
equivalent screening to women with a mutation 
15
. Much is still unknown about the 4 
content of information that is shared within families or whether the accuracy of the 5 
information communicated and recalled impacts on decisions to seek genetic testing 6 
or risk management options.  7 
 8 
Few studies have investigated the accuracy of the information recalled by cancer 9 
patients or their relatives following identification of a BRCA1/2 gene mutation. 10 
A Belgian study of 107 first-degree relatives of 14 patients with a BRCA1/2 mutation 11 
reported low levels of knowledge amongst patients and relatives about hereditary 12 
breast and ovarian cancer, dominant inheritance, the availability of predictive testing, 13 
cancer risks, risk reducing options and the possibility of prenatal diagnosis 
16
. Levels 14 
of knowledge about hereditary cancer were found to be higher amongst patients than 15 
relatives.  More recently a Dutch study found that patients’ recall of information 16 
about BRCA1/2 genetic test results was similar to the information provided during 17 
genetic counselling but there were few similarities between the information actually 18 
communicated to the patient and the information recalled by their relatives 
17
. The 19 
authors concluded that the information was re-interpreted at each stage of the 20 
information transfer, highlighting problems with the accuracy of information 21 
communicated to relatives by patients. 22 
 23 
Encouraging and facilitating family communication is a key element of genetic 24 
counselling 
5,9
. However, an international review found that none of the guidelines 25 
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about family communication in genetics detailed how or what information should be 1 
communicated 
18
. A worldwide survey of genetic counselling practice in facilitating 2 
family communication found that, although 90% of participants stated that they 3 
always identify at risk relatives and encourage family communication, 41% never 4 
write a letter specifically for at risk relatives 
19
.  5 
 6 
This observational study aimed to (i) compare the accuracy of information amongst 7 
patients and relatives following genetic counselling with index patients about a 8 
BRCA1/2 mutation; (ii) compare the accuracy of information about general genetics 9 
and hereditary cancer and (iii) examine whether accuracy amongst relatives improved 10 
when information was provided directly by genetics health professionals. This was 11 
part of a larger study examining the experience and process of family communication 12 
using qualitative and quantitative methods. The qualitative analysis has been reported 13 
elsewhere 
8,11,20
.  14 
 15 
MATERIALS AND METHODS 16 
Participants: Eligible participants were women affected by breast or ovarian cancer 17 
who had been found to have a pathogenic BRCA1/2 mutation following diagnostic 18 
genetic testing at one of two UK NHS Regional Genetics Centres (patients), and their 19 
‘at risk’ biological relatives with whom they had shared the result (relatives). The 20 
study sample consisted of 10 patients with breast and/ or ovarian cancer and 22 of 21 
their relatives (at least two ‘at risk’ first, second or third-degree relatives of each 22 
patient).   23 
 24 
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Recruitment: All patients receiving diagnostic BRCA1/2 genetic test results 1 
underwent pre-test genetic counselling and results were given during a subsequent 2 
consultation by a genetics health professional (genetic counsellor or clinical 3 
geneticist). Patients were recruited after blood was taken for genetic testing but prior 4 
to receiving their test result.  The patients recruited their relatives after they had 5 
shared the result with them. These relatives may or may not have undergone 6 
predictive testing at the time of interview. All participants were over the age of 18 and 7 
spoke English. Only families where the patient and at least two relatives were 8 
interviewed were included.  9 
 10 
Data were collected between 2006 and 2008. Health professionals consented to audio-11 
recording of the consultations and analysis of clinic letters. Participants consented to 12 
audio-recording of consultations (for patients only) and research interviews. Ethics 13 
approval was obtained.  14 
 15 
Procedure: Two researchers, who were employed consecutively on the project, 16 
carried out all of the semi-structured interviews. The patients were interviewed on one 17 
occasion approximately four weeks after receiving the genetic test result. The 18 
interview schedule addressed understanding of genetic risk and implications for 19 
themselves and family, whether or not they had informed relatives of the result, how 20 
and what information they had given to relatives and how this was received. Specific 21 
knowledge questions were not asked. One semi-structured interview was 22 
subsequently carried out with each relative, again using an interview schedule. 23 
Relatives were asked for details of what and how they were told about the mutation 24 
by the patient (i.e. what words were used, how they reacted to the information, how 25 
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they perceived their own risk, whether they intended to do anything as a result of the 1 
information and the sources of their information). Again specific knowledge questions 2 
were not asked.  3 
 4 
The transcripts of the clinic consultations and the post-consultation summary letters 5 
were systematically searched for information that had been communicated by the 6 
health professional. This was grouped into ‘general genetics information’ (i.e. 7 
inheritance, the gene involved and genetic counselling/testing for relatives) and 8 
‘hereditary cancer information’ (i.e. cancer risk for affected and unaffected 9 
individuals and risk management options). Interview transcripts were systematically 10 
searched for reference to the information that had been communicated by the genetics 11 
health professional. The research team agreed on the coding framework and 12 
definitions of accuracy. The transcripts of the patients and relatives were coded 13 
independently by two researchers for accuracy compared to the information provided 14 
by the health professional. Participants’ statements that were correct compared to the 15 
information provided by the health professional were coded as accurate. Statements 16 
that were incorrect, unknown, not mentioned or incomplete were coded as inaccurate. 17 
Where a participant made more than one reference to information, these were grouped 18 
together and coded once. For example, if the participant had made two references to 19 
the same information, one accurate and one inaccurate, this was coded as inaccurate. 20 
Relatives’ transcripts were also coded for the reported sources of information as 21 
follows: information provided by the patient only (coded as information level 1); 22 
information provided by the patient and the genetics consultation or a letter from the 23 
health professional (coded as information level 2): and information provided by the 24 
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patient and the genetics consultation and a letter from the health professional (coded 1 
as information level 3).   2 
 3 
Analysis: Accurate and inaccurate statements were counted using Content Analysis 
21
 4 
and analysed using SPSS. Because there were different numbers of relatives in each 5 
family (either two or three) the mean number of inaccuracies for the relatives in each 6 
family were calculated. Accuracy of recall of information for patients was 7 
operationalised as the number of accurate statements made during the interview 8 
divided by the total number of accurate and inaccurate statements so that if there were 9 
five accurate statements and five inaccurate statements, the accuracy score was 0.5 10 
(5/10). Accuracy of recall of information for relatives involved calculating the 11 
accuracy score for each relative interviewed, and then calculating the mean score for 12 
the relatives as a whole. Thus if there were two relatives in the family and one had an 13 
accuracy score of 0.5 and the other had a score of 0.3, the score for the relatives 14 
would be 0.4. Accuracy of recall scores were calculated separately for genetics 15 
information and hereditary cancer information and for the two combined. 16 
A priori hypotheses concerning differences in accuracy between patients and relatives 17 
and between genetics and hereditary cancer information were tested using the 18 
Wilcoxon Signed Ranks test. This evaluated differences between matched pairs of 19 
numbers with no assumption about the underlying distribution of those numbers. The 20 
alpha was set to 0.05, 2-tailed. Although the hypotheses were directional, it is rare to 21 
see the use of a 1-tailed test in this area and the sample size was small. Given this, a 22 
conservative approach was adopted and convention of a significance level set at 23 
p<0.05 was followed. 24 
 25 
 Accuracy of information about a BRCA1/2 mutation 
 
9 
Sources of relatives’ information: The a priori hypothesis, that accuracy of recall of 1 
information by relatives is positively associated with the number of sources of 2 
information, was tested using a Spearman’s rank order correlation coefficient. The 3 
alpha was set to 0.05, 2-tailed.  4 
 5 
RESULTS 6 
Participants: Of the patients, six had a BRCA1 mutation and four had a BRCA2 7 
mutation; five had breast cancer only, two had ovarian cancer only and three had 8 
breast and ovarian cancer. The mean age of the patients was 55.5 years (range 34 to 9 
71). The mean age at diagnosis was 40.8 years for breast cancer (range 28 to 59) and 10 
56.2 years for ovarian cancer (range 45 to 63). Amongst the relatives, 18 were 11 
unaffected with cancer, two had breast cancer (age 45 and 51 years), one had ovarian 12 
cancer (age 55) and one had oral cancer  (age 63); there were six daughters, four sons, 13 
six sisters, two brothers, two nieces and two cousins; 12 were untested, three tested 14 
positive, four tested negative and three were awaiting results. The mean age of the 15 
relatives was 37.1 years (range 20 to 65) (These data are shown in the supplementary 16 
Table).  17 
  18 
Volume of information communicated to patients: Overall, 209 information 19 
statements were communicated to the patients: 29% (61) relating to general genetics 20 
and 71% (148) relating to hereditary cancer. The mean number of information 21 
statements communicated to patients was 21 (range 16 to 26).  22 
 23 
Accuracy of recall: The percentage agreement for independent coding of accuracy of 24 
participants’ statements by two members of the research team (CJ and CD) was 94% 25 
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(627/667). All disagreements were readily resolved. Table 1 shows accuracy and 1 
inaccuracy across all families for all information (the relatives’ score shown is the 2 
mean score for the relatives in each family).  3 
[Insert Table 1] 4 
Accuracy of recall of information overall (in relation to genetics and hereditary cancer 5 
combined) was low amongst the patients following genetic counselling (53%). 6 
Accuracy amongst the relatives was significantly lower (30%) than amongst the 7 
patients themselves (Wilcoxon Signed Ranks test z=2.40, p=0.017, 2-tailed). Overall 8 
accuracy of patients and relatives is shown in Table 2.  9 
[Insert Table 2) 10 
The accuracy of recall for patients and relatives combined was greater for general 11 
genetics information (60%) than for hereditary cancer information (36%) (z=2.80, 12 
p=0.005). There was a trend suggesting that this difference was greater for patients 13 
than for relatives (Wilcoxon Signed Ranks test, z=1.89, p=0.056). Table 3 shows 14 
accuracy and inaccuracy about general genetics and hereditary cancer information for 15 
patients and relatives.  16 
[Insert Table 3] 17 
Sources of information:  There was a positive association between the accuracy of 18 
recall by relatives and the number of sources of information (Spearman’s rank order 19 
correlation coefficient R=0.88, p=0.001) (Table 4). This was the case both for 20 
hereditary cancer (R=0.83, p=0.003) and general genetics information (R=0.72, 21 
p=0.02).  22 
[Insert Table 4] 23 
DISCUSSION 24 
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Only 53% of the information about general genetics and hereditary cancer recalled by 1 
patients was accurate. The reasons for the low levels of accuracy amongst patients 2 
were not investigated in this study. However, it is possible that the high volume of 3 
information communicated by health professionals (mean of 21 statements of 4 
information) may have contributed to the low recall amongst patients, as suggested by 5 
previous authors 
22,23
.  6 
 7 
Accuracy of recall amongst relatives was significantly lower than accuracy amongst 8 
patients. The reduction in accuracy of recall as information was communicated to 9 
relatives is consistent with the findings of previous studies 
16,24
. Patients and relatives 10 
differed in their experiences of cancer and their age at interview (patients’ means age 11 
was 55.5 and relatives’ means age was 37.1). These differences may have contributed 12 
to the lower level of accuracy amongst relatives. As previous research has suggested, 13 
there are a number of possible reasons why information may not be recalled following 14 
genetic counselling about a BRCA1/2 mutation including lack of understanding 
24
, 15 
individual interpretation or perceived lack of relevance 
8
 and not valuing the 16 
information sufficiently to retain it 
11
. 17 
 18 
A lower level of accuracy was seen about hereditary cancer than genetics amongst 19 
patients and relatives. This supports the findings of a previous study of accuracy of 20 
recall of patients with cancer and their relatives which found that information about 21 
cancer risk was the least accurately recalled 
25
. However, in a study of first-degree 22 
relatives undergoing predictive testing for BRCA1/2 mutations, higher levels of 23 
accuracy about hereditary cancer than inheritance were reported 
16
. For the cancer 24 
patients in this study, general genetics information would have been addressed during 25 
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pre-test genetic counselling, whereas specific hereditary cancer information may not 1 
have been discussed in detail prior to learning the genetic test result.  The patients 2 
may therefore have been less familiar with some or all of the hereditary cancer 3 
information than with the general genetics information. This may have contributed to 4 
the lower levels of accuracy about hereditary cancer amongst patients and relatives.  5 
 6 
Giving information about the implications of genetic testing in order to enable 7 
informed decision-making is an integral component of genetic counselling 
26,27
. Yet it 8 
is not known whether the accuracy of information recalled about an identified gene 9 
mutation impacts on the decisions that individuals make regarding genetic testing or 10 
risk management.  A systematic review of the effect of communicating DNA based 11 
risk assessments on risk reducing behaviour found that there was insufficient evidence 12 
to draw conclusions for practice 
28
.  Ley’s model of effective communication in 13 
medical practice stresses the importance of accurate recall, satisfaction and adherence 14 
for understanding 
29
. However, Fuzzy Trace Theory suggests that individuals encode 15 
multiple representations of information with varying precision, enabling 16 
understanding of the ‘gist’ rather than the detail of information 30. It is possible that 17 
understanding the gist of the information is sufficient for individuals to make 18 
decisions in this context. It is unclear whether there is a link between accurately 19 
recalling the information and the uptake of genetic testing and screening or the 20 
information individuals require about a BRCA1/2 mutation in order to make these 21 
decisions.   22 
 23 
Relatives who received information from several sources, including the genetics 24 
health professional, reported a higher level of accurate information recall than those 25 
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who received information from the patient alone. This suggests that multiple sources 1 
of information may improve the accuracy of information recalled by relatives. 2 
However, why this was the case or how accuracy was improved was not investigated 3 
by the study. Previous research has suggested that information provided to relatives 4 
by genetics health professionals may involve less interpretation and emotion than that 5 
provided by index patients 
24
. This would also be in line with Family Systems Theory 6 
31
 in which illness, or in this case the genetic test result, influences and is influenced 7 
by the individuals within the family who interpret and manage interactions relating to 8 
the illness.  9 
 10 
The patients in this study were tested after completing cancer treatment and were 11 
counselled by genetics health professionals with greater knowledge and expertise in 12 
genetics than cancer. The integration of genetics into mainstream medicine will 13 
inevitably shift the timing, location and focus of the delivery of information about 14 
genetic testing. These discussions are increasingly likely to take place prior to, or 15 
during, treatment and to be delivered by health professionals with greater knowledge 16 
and expertise in cancer than genetics. Although these findings are not directly 17 
transferable to that scenario, they may provide a basis for further research.  18 
 19 
This study was limited to a self-selected sample and the participants were not assessed 20 
on recall of specific information. Accuracy of the information recalled compared with 21 
the information communicated by the health professional was drawn from qualitative 22 
data and involved judgements made by the research team but the use of an agreed 23 
definition of accuracy, the coding framework and high level of agreement by two 24 
researchers coding independently strengthened the study. Given changes in public 25 
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awareness of genetics and in the availability of verbal and written provision of 1 
information, there may have been changes in the understanding by relatives since the 2 
time of data collection in this study from 2006 to 2008. It follows that the findings 3 
may be different if the study were to be repeated now with a new sample.  In order to 4 
asses the generalizability of the findings, they would need to be replicated on a larger 5 
scale and evaluated and in other settings, with other populations and with patients 6 
undergoing genetic testing close to diagnosis.  7 
 8 
Further study is needed to examine the reasons for the low level of accuracy, the 9 
relevance of the information not accurately recalled, the impact of the inaccurate 10 
recall and factors that could influence recall, such as educational level, meaning, 11 
context, experience and emotion. Further research would be helpful to identify the 12 
information that individuals require in order to make risk management decisions and 13 
the extent to which accurate recall of information about a BRCA1/2 mutation is 14 
necessary for such decision-making.   15 
 16 
CONCLUSION 17 
These findings suggest that following identification of a BRCA1/2 mutation in the 18 
clinical genetics setting, accuracy of recall of information amongst patients and 19 
relatives is low; particularly about cancer risks and risk management options. The 20 
findings highlight the importance of communicating clear and accurate information 21 
about general genetics and hereditary cancer to patients and relatives once a gene 22 
mutation is identified and suggest that accuracy of recall amongst relatives may be 23 
improved when the information is communicated via multiple sources of information, 24 
including direct contact with genetics health professionals. These findings provide 25 
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evidence supporting the concern that at-risk relatives may understand little about their 1 
cancer risks and risk management options which could be important for clinical 2 
practice.  3 
 4 
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